Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2011 4
2012 3
2013 3
2014 2
2015 1
2016 3
2017 2
2018 2
2019 3
2020 6
2021 4
2022 1
2023 4
2024 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Islamic fasting and multiple sclerosis.
Jahromi SR, Sahraian MA, Ashtari F, Ayromlou H, Etemadifar M, Ghaffarpour M, Mohammadianinejad E, Nafissi S, Nickseresht A, Shaygannejad V, Togha M, Torabi HR, Ziaie S. Jahromi SR, et al. Among authors: ayromlou h. BMC Neurol. 2014 Mar 22;14:56. doi: 10.1186/1471-2377-14-56. BMC Neurol. 2014. PMID: 24655543 Free PMC article. Review.
Exosome Content-Mediated Signaling Pathways in Multiple Sclerosis.
Mohammadinasr M, Montazersaheb S, Ayromlou H, Hosseini V, Molavi O, Hejazi MS. Mohammadinasr M, et al. Among authors: ayromlou h. Mol Neurobiol. 2024 Aug;61(8):5404-5417. doi: 10.1007/s12035-023-03862-2. Epub 2024 Jan 8. Mol Neurobiol. 2024. PMID: 38191693 Review.
Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivity.
Abolfazli R, Sahraian MA, Shaygannejad V, Ashtari F, Shahmohammadi S, Poursadeghfard M, Baghbanian SM, Majdinasab N, Nahayati MA, Hosseini S, Azarfam JY, Navardi S, Torabi HR, Ayromlou H, Saeidi M, Talebi M, Nikseresht A, Niknam Z, Azimi A, Sedighi B, Ghiasian M, Ghalyanchi-Langroodi H, Pourakbar E, Heidari H, Kamali H, Mohammadianinejad E, Ghaffari M, Mosarrezaii A, Bayati A, Yaseri M, Shali A, Samadzadeh S. Abolfazli R, et al. Among authors: ayromlou h. J Clin Neurosci. 2026 Apr;146:111877. doi: 10.1016/j.jocn.2026.111877. Epub 2026 Jan 28. J Clin Neurosci. 2026. PMID: 41610777 Clinical Trial.
Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations.
Sahraian MA, Moghadasi AN, Azimi AR, Asgari N, H Akhoundi F, Abolfazli R, Alaie S, Ashtari F, Ayromlou H, Baghbanian SM, Moghadam NB, Fatehi F, Foroughipour M, Langroodi HG, Majdinasab N, Nickseresht A, Nourian A, Shaygannejad V, Torabi HR. Sahraian MA, et al. Among authors: ayromlou h. Mult Scler Relat Disord. 2017 Nov;18:144-151. doi: 10.1016/j.msard.2017.09.015. Epub 2017 Sep 25. Mult Scler Relat Disord. 2017. PMID: 29141797 Review.
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial.
Sahraian MA, Abolfazli R, Shaygannejad V, Ashtari F, Majdinasab N, Navardi S, Baghbanian SM, Sedighi B, Naser Moghadasi A, Nahayati MA, Ghalyanchi Langroodi H, Mohammadianinejad SE, Beladi Moghadam N, Ayromlou H, Nikseresht A, Ghiasian M, Razazian N, Asadollahzadeh E, Sabzvari A, Kafi H, Albooyeh S. Sahraian MA, et al. Among authors: ayromlou h. Sci Rep. 2024 Oct 22;14(1):24921. doi: 10.1038/s41598-024-75745-y. Sci Rep. 2024. PMID: 39438591 Free PMC article. Clinical Trial.
Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY).
Shaygannejad V, Ashtari F, Saeidi M, Beladi Moghadam N, Ghalyanchi Langroodi H, Baghbanian SM, Abolfazli R, Ghiasian M, Ayromlou H, Asadollahzadeh E, Sabzvari A, Kafi H, Azimi Saeen A. Shaygannejad V, et al. Among authors: ayromlou h. Mult Scler Relat Disord. 2024 Oct;90:105839. doi: 10.1016/j.msard.2024.105839. Epub 2024 Aug 20. Mult Scler Relat Disord. 2024. PMID: 39217809 Clinical Trial.
41 results